HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Drug Pipeline
RCT
Review of Therapeutic Options for Carbapenem-Resistant Enterobacterales
New Weapons Emerge in the Fight Against Deadly Superbugs
This review summarizes available and emerging therapies for carbapenem-resistant Enterobacterales. It highlights the lack of robust clinical…
New drug combinations offer hope for patients facing deadly superbugs that resist almost all current antibiotics.
Frontiers
Apr 18, 2026
Infectious Disease
Meta-analysis
Meta-analysis finds no mortality difference between CA and CT for drug-resistant P. aeruginosa infections
Which antibiotic works better for dangerous drug-resistant infections?
A meta-analysis of 10 observational studies including 1409 patients with drug-resistant P. aeruginosa infections found no significant differ…
Two powerful new antibiotics show equal survival rates for patients fighting dangerous, drug-resistant infections.
Apr 2, 2026